Fact checked by Nick Blackmer The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...
There’s no polite way to discuss this, but so blow the winds of change. The term “fart walks” is trending right now, though ...
The highest rates of Alzheimer’s disease in Iowa are found in the state’s northwest Iowa counties, according to a release ...
Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study. The research, ...
As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...
New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...
A new diagnostic tool is being developed which could one day allow doctors to diagnose Alzheimer's disease through a simple ...
UMass Memorial Health – Harrington Hospital has been selected to participate in a nationwide fellowship program to create ...
A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback